Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin + Topical Steroid vs Topical Steroid Alone for Oral Submucous Fibrosis
NCT07891130Completed
- Sponsor
- Liaquat College of Medicine and Dentistry
- Start
- Oct 2025
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Randomised, single-blind trial of curcumin in Oral submucous fibrosis (OSF) (2 arms), sponsored by Liaquat College of Medicine and Dentistry. Primary endpoint: Interincisal Mouth Opening at 6 months. Started Oct 2025; status: completed.
02
Drugs
curcumin
03
Conditions
Oral submucous fibrosis (OSF)
Beyond the preview
Go deeper on NCT07891130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07891130.